[Federal Register Volume 66, Number 78 (Monday, April 23, 2001)]
[Notices]
[Pages 20485-20486]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-9954]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[Docket No. 50-336]
Northeast Nuclear Energy Company, et al. Millstone Nuclear Power
Station, Unit No. 2; Notice of Consideration of Issuance of Amendment
to Facility Operating License and Opportunity for a Hearing
The U.S. Nuclear Regulatory Commission (the Commission) is
considering issuance of an amendment to Facility Operating License No.
DPR-65, issued to Northeast Nuclear Energy Company, et al. (the
licensee), for operation of the Millstone Nuclear Power Station, Unit
No. 2 (MP2), located in New London County, Connecticut.
The proposed amendment would revise the MP2 Final Safety Analysis
Report (FSAR), Chapter 14, description of the Steam Generator Tube
Rupture (SGTR) event and its associated radiological dose consequences.
The changes are not the result of hardware changes to the plant or
changes in operating practices. Rather, the changes are the result of
incorporating a postulated loss of offsite power into the event
analyses as well as revised assumptions and analysis methodology. The
proposed FSAR changes show that the postulated dose consequences for
the updated SGTR analysis are higher than the dose consequences for the
previous analysis.
Specifically, the proposed changes in the assumptions associated
with the SGTR analyses will increase the dose consequences for two
hypothetical cases: Case 1 involves a spike in the reactor coolant
iodine activity level as a result of the SGTR accident; Case 2 involves
a pre-accident spike in the iodine activity level. For Case 1, the
revised calculations result in the following changes to the postulated
accident doses for the Exclusion Area Boundary (EAB), and Low
Population Zone (LPZ): EAB thyroid dose increases from .160 REM to 15.4
REM; EAB whole body dose increases from .146 REM to 2.2 REM; LPZ
thyroid dose increases from .017 REM to 2.1 REM; and, LPZ whole body
dose increases from .045 REM to .3 REM. For Case 2, the postulated
doses would change as follows: EAB thyroid dose increases from .813 REM
to 27.8 REM; EAB whole body dose increases from .146 REM to .8 REM; LPZ
thyroid dose increases from .085 REM to 3.7 REM; and LPZ whole body
dose increases from .045 REM to .1 REM.
Before issuance of the proposed license amendment, the Commission
will have made findings required by the Atomic Energy Act of 1954, as
amended (the Act) and the Commission's regulations.
By May 21, 2001, the licensee may file a request for a hearing with
respect to issuance of the amendment to the subject facility operating
license and any person whose interest may be affected by this
proceeding and who wishes to participate as a party in the proceeding
must file a written request for a hearing and a petition for leave to
intervene. Requests for a hearing and a petition for leave to intervene
shall be filed in accordance with the Commission's ``Rules of Practice
for Domestic Licensing Proceedings'' in 10 CFR part 2. Interested
persons should consult a current copy of 10 CFR 2.714 which is
available at the Commission's Public Document Room, located at One
White Flint North, 11555 Rockville Pike (first floor), Rockville,
Maryland and accessible electronically through the ADAMS Public
Electronic Reading Room link at the NRC Web site (http://www.nrc.gov).
If a request for a hearing or petition for leave to intervene is filed
by the above date, the Commission or an Atomic Safety and Licensing
Board, designated by the Commission or by the Chairman of the Atomic
Safety and Licensing Board Panel, will rule on the request and/or
petition; and the Secretary or the designated Atomic Safety and
Licensing Board will issue a notice of hearing or an appropriate order.
As required by 10 CFR 2.714, a petition for leave to intervene
shall set forth with particularity the interest of the petitioner in
the proceeding, and how that interest may be affected by the results of
the proceeding. The petition should specifically explain the reasons
why intervention should be permitted with particular reference to the
following factors: (1) The nature of the petitioner's right under the
Act to be made a party to the proceeding; (2) the nature and extent of
the petitioner's property, financial, or other interest in the
proceeding; and (3) the possible effect of any order which may be
entered in the proceeding on the petitioner's interest. The petition
should also identify the specific aspect(s) of the subject matter of
the proceeding as to which petitioner wishes to intervene. Any person
who has filed a petition for leave to intervene or who has been
admitted as a party may amend the petition without requesting leave of
the Board up to 15 days prior to the first prehearing conference
scheduled in the proceeding, but such an amended petition must satisfy
the specificity requirements described above.
[[Page 20486]]
Not later than 15 days prior to the first prehearing conference
scheduled in the proceeding, a petitioner shall file a supplement to
the petition to intervene which must include a list of the contentions
which are sought to be litigated in the matter. Each contention must
consist of a specific statement of the issue of law or fact to be
raised or controverted. In addition, the petitioner shall provide a
brief explanation of the bases of the contention and a concise
statement of the alleged facts or expert opinion which support the
contention and on which the petitioner intends to rely in proving the
contention at the hearing. The petitioner must also provide references
to those specific sources and documents of which the petitioner is
aware and on which the petitioner intends to rely to establish those
facts or expert opinion. Petitioner must provide sufficient information
to show that a genuine dispute exists with the applicant on a material
issue of law or fact. Contentions shall be limited to matters within
the scope of the amendment under consideration. The contention must be
one which, if proven, would entitle the petitioner to relief. A
petitioner who fails to file such a supplement which satisfies these
requirements with respect to at least one contention will not be
permitted to participate as a party.
Those permitted to intervene become parties to the proceeding,
subject to any limitations in the order granting leave to intervene,
and have the opportunity to participate fully in the conduct of the
hearing, including the opportunity to present evidence and cross-
examine witnesses.
A request for a hearing or a petition for leave to intervene must
be filed with the Secretary of the Commission, U.S. Nuclear Regulatory
Commission, Washington, DC 20555-0001, Attention: Rulemakings and
Adjudications Staff, or may be delivered to the Commission's Public
Document Room, located at One White Flint North, 11555 Rockville Pike
(first floor), Rockville, Maryland, by the above date. A copy of the
petition should also be sent to the Office of the General Counsel, U.S.
Nuclear Regulatory Commission, Washington, DC 20555-0001, and to
Lillian M. Cuoco, Esq., Senior Nuclear Counsel, Northeast Utilities
Service Company, P.O. Box 270, Hartford, Connecticut, attorney for the
licensee.
Nontimely filings of petitions for leave to intervene, amended
petitions, supplemental petitions and/or requests for hearing will not
be entertained absent a determination by the Commission, the presiding
officer or the presiding Atomic Safety and Licensing Board that the
petition and/or request should be granted based upon a balancing of the
factors specified in 10 CFR 2.714(a)(1)(i)-(v) and 2.714(d).
If a request for a hearing is received, the Commission's staff may
issue the amendment after it completes its technical review and prior
to the completion of any required hearing if it publishes a further
notice for public comment of its proposed finding of no significant
hazards consideration in accordance with 10 CFR 50.91 and 50.92.
For further details with respect to this action, see the
application for amendment dated December 21, 2000, which is available
for public inspection at the Commission's Public Document Room, located
at One White Flint North, 11555 Rockville Pike (first floor),
Rockville, Maryland, and accessible electronically through the ADAMS
Public Electronic Reading Room link at the NRC Web site (http://www.nrc.gov).
Dated at Rockville, Maryland, this 17th day of April 2001.
For the Nuclear Regulatory Commission.
Daniel S. Collins,
Project Manager, Section 2, Project Directorate I, Division of
Licensing Project Management, Office of Nuclear Reactor Regulation.
[FR Doc. 01-9954 Filed 4-20-01; 8:45 am]
BILLING CODE 7590-01-P